Loading…
Vir Biotechnology, Inc. is projected to rise to $10.40 by 2027, a +20% move from its current price of $8.66. VIR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $8.45 | $8.66 | $8.88 | +0.02% |
| Aug 3 | $8.37 | $8.66 | $8.97 | +0.04% |
| Aug 4 | $8.30 | $8.67 | $9.04 | +0.06% |
| Aug 5 | $8.25 | $8.67 | $9.11 | +0.09% |
| Aug 6 | $8.20 | $8.67 | $9.16 | +0.11% |
| Aug 7 | $8.16 | $8.67 | $9.21 | +0.13% |
| Aug 8 | $8.12 | $8.67 | $9.26 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.12 | $8.67 | $9.26 | +0.15% |
| Week 2 | $7.92 | $8.69 | $9.53 | +0.30% |
| Week 3 | $7.77 | $8.70 | $9.74 | +0.45% |
| Week 4 | $7.65 | $8.71 | $9.93 | +0.60% |
| Week 5 | $7.54 | $8.72 | $10.10 | +0.75% |
| Week 6 | $7.45 | $8.74 | $10.25 | +0.90% |
| Week 7 | $7.36 | $8.75 | $10.40 | +1.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors.
Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Vir Biotechnology, Inc. (VIR) operates in the Healthcare category. The stock’s current price is $8.69 with a market cap of $1.47B, and it holds a rank of 2119. The near-term price outlook for 2026 shows an average price of $8.69, a min of $5.79, and a max of $10.97, with a neutral sentiment and ROI of 0.
The longer-term forecast indicates bullish upside across 2027–2050, with rising averages and ROIs culminating in a 2050 average of $53.36 and a max of $92.79, supported by a generally bullish sentiment.
A major floor 13.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.2% away) — a key level to hold.
The nearest ceiling, 20.4% above — a clean break opens room to run.
A major ceiling 28.1% above — clearing it would confirm fresh momentum.
Key VIR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VIR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.77 | Sell | $8.80 | Sell |
| MA 10 | $8.99 | Sell | $8.98 | Sell |
| MA 20 | $9.43 | Sell | $9.20 | Sell |
| MA 50 | $9.31 | Sell | $9.33 | Sell |
| MA 100 | $9.45 | Sell | $9.08 | Sell |
| MA 200 | $8.07 | Buy | $8.41 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.02 | Neutral |
| Stoch RSI (14) | 20.58 | Neutral |
| CCI (20) | -115.83 | Sell |
| Williams %R (14) | -97.94 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -9.89 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 2.06 | Buy |
| TRIX (15) | -0.16 | Sell |
| Awesome (5,34) | -0.72 | Sell |
| Ultimate (7,14,28) | 30.23 | Neutral |
| Momentum (10) | -0.77 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 8.65 | Buy |
| ADX (14) | 15.68 | Neutral |
| ATR (14) | 0.21 | Info |
Sentiment: NEUTRAL. RSI(14): 50. SMA50: $9.33. SMA200: $7.98. Support: $8.25. Resistance: $10.43. The 30-day range spans from $7.47 to $10.11. These near-term technicals suggest limited downside risk but potential resistance near $10.43 before any breakout.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.79 | $8.66 | $10.91 | 0% | Neutral | |
| $8.37 | $10.40 | $13.62 | +20% | Bullish | |
| $8.84 | $11.27 | $15.27 | +30% | Bullish | |
| $9.05 | $11.78 | $16.40 | +36% | Bullish | |
| $8.96 | $11.88 | $16.91 | +37% | Bullish | |
| $9.58 | $12.91 | $18.76 | +49% | Bullish | |
| $10.34 | $14.16 | $20.93 | +63% | Bullish | |
| $11.35 | $15.76 | $23.68 | +82% | Bullish | |
| $13.23 | $18.62 | $28.40 | +115% | Bullish | |
| $13.73 | $19.58 | $30.27 | +126% | Bullish | |
| $18.30 | $27.68 | $45.32 | +220% | Bullish | |
| $29.69 | $49.64 | $88.43 | +473% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.79 | $8.66 | $10.33 | +0.00% |
| September 2026 | $7.28 | $8.59 | $10.41 | -0.79% |
| October 2026 | $7.44 | $8.83 | $10.80 | +2.77% |
| November 2026 | $7.48 | $8.93 | $11.00 | +1.08% |
| December 2026 | $7.33 | $8.79 | $10.91 | -1.52% |
Click any year to see its month-by-month VIR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VIR price prediction for 2026 points to an average of $8.66 (low $5.79, high $10.91) — a potential gain of 0% on today's $8.66. Price action looks broadly range-bound.
In 2027, VIR is projected to trade between $8.37 and $13.62, averaging $10.40 — a potential gain of +20% from today's $8.66. That is up +20% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Vir Biotechnology, Inc.'s 2028 outlook centres on $11.27, within a $8.84 to $15.27 range. That is up +8% on the projected 2027 average. That marks a +30% change versus current levels. Momentum favours further upside here.
By 2029, VIR could reach as high as $16.40, with a base case around $11.78 and support toward $9.05 — roughly +36% from $8.66. Buyers look set to stay in control over this stretch.
Expect VIR to range from $8.96 to $16.91 through 2030. The $11.88 average target implies a +37% move from current prices. That is up +1% on the projected 2029 average. Momentum favours further upside here.
The VIR price prediction for 2031 points to an average of $12.91 (low $9.58, high $18.76) — a potential gain of +49% on today's $8.66. Buyers look set to stay in control over this stretch.
In 2032, VIR is projected to trade between $10.34 and $20.93, averaging $14.16 — a potential gain of +63% from today's $8.66. That is up +10% on the projected 2031 average. Momentum favours further upside here.
Vir Biotechnology, Inc.'s 2033 outlook centres on $15.76, within a $11.35 to $23.68 range. That is up +11% on the projected 2032 average. That marks a +82% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, VIR could reach as high as $28.40, with a base case around $18.62 and support toward $13.23 — roughly +115% from $8.66. Momentum favours further upside here.
Expect VIR to range from $13.73 to $30.27 through 2035. The $19.58 average target implies a +126% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The VIR price prediction for 2040 points to an average of $27.68 (low $18.30, high $45.32) — a potential gain of +220% on today's $8.66. Momentum favours further upside here.
In 2050, VIR is projected to trade between $29.69 and $88.43, averaging $49.64 — a potential gain of +473% from today's $8.66. That is up +79% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in VIR today (≈ 115.473441 VIR) could be worth
$5,732.14
+$4,732.14 (+473%) by 2050 · US Dollar
Based on the average projected VIR price of $49.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VIRwould be worth at today's price.
$1,000 invested in VIR on Jul 31, 2025 (≈ 197.238652 VIR) would be worth
$1,708.09
+$708.09 (+70.8%) today · 1.71× · US Dollar
Based on a VIR entry price of $5.07 vs. today's $8.66.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.69 | $996.55 | -0.3% |
| 1 month ago | $9.56 | $905.86 | -9.4% |
| 3 months ago | $10 | $866 | -13.4% |
| 6 months ago | $7.71 | $1,123.22 | +12.3% |
| 1 year ago | $5.07 | $1,708.09 | +70.8% |
| All time (5.0y) ago | $35.86 | $241.49 | -75.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VIR forecast.
Our base-case forecast reaches $17.00 around 2034.
Implied market cap at $17.00: $2.87B
The multi-year forecast depicts a bullish trajectory with steadily higher averages and ROI. By 2030 the model shows an average price of $12.40 and a max of $17.44, with a min of $9.45 and an expected ROI of 42.7%; sentiment is BULLISH. The path continues to 2040, where the average is $29.50 and the max is $47.35, with an ROI of 239.5% and bullish sentiment.
By 2050 the average reaches $53.36 and the max $92.79, with an ROI of 514% and a bullish stance. These are estimates, not guarantees, and carry inherent uncertainty as market conditions change.
Tap a question to reveal the answer.
Min $9.45, Avg $12.40, Max $17.44; ROI 42.7; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising average prices and ROIs, though 2026 is neutral; these are estimates and not guarantees.
Yes. The 2050 forecast shows Avg $53.36 and Max $92.79, so a $50 target would be within the long-term forecast.
RSI(14) 50; SMA50 $9.33; SMA200 $7.98; Support $8.25; Resistance $10.43; 30-day range $7.47–$10.11.
Vir Biotechnology, Inc. Community Discussion
0Share your Vir Biotechnology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.